A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence

European Neuropsychopharmacology

Volumn 20, Issue 11, 2010, Pages 823-828

  Grant, Jon E ^a   Odlaug, Brian L ^a   Kim, Suck Won ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

Author keywords

Addiction; Dependence; Dopamine; Glutamate; Methamphetamine; Pharmacotherapy

Indexed keywords

ACETYLCYSTEINE; METHAMPHETAMINE; NALTREXONE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; MALE; NAUSEA; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; TOXICITY TESTING; TREATMENT OUTCOME; URINALYSIS;

ACETYLCYSTEINE; ADULT; AMPHETAMINE-RELATED DISORDERS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; NALTREXONE; YOUNG ADULT;

EID: 77957020829     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.06.018     Document Type: Article

References (28)

1. Batki, S.L., Moon, J., Bradley, M., et al., 1999. Fluoxetine in methamphetamine dependence-a controlled trial: preliminary analysis. in: L.S. Harris, ed. Problems of Drug Dependence 1999. Proceedings of the 61st Annual Scientific Meeting of the College on Problems of Drug Dependence, Inc. US Government Printing Office. 2000:235. NIDA research monograph 180, NIH publication 00-4737, Washington, DC.
2. Berigan T.R., Russell M.L. Treatment of methamphetamine cravings with bupropion: a case report. Prim. Care. Companion J. Clin. Psychiatry 2001, 3:267-268.
3. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W. 1995. Structured Clinical Interview for DSM-IV-Patient Edition (SCID-I/P, Version 2.0). Biometrics Research Department, New York State Psychiatric Institute, New York.
4. Flannery B.A., Volpicelli J.R., Pettinati H.M. Psychometric properties of the Penn Alcohol Craving Scale. Alcohol. Clin. Exp. Res. 1999, 23:1289-1295.
5. Frisch M.B., Cornell J., Villaneuva M. Clinical validation of the Quality of Life Inventory: a measure of life satisfaction for use in treatment planning and outcome assessment. Psychol. Assess. 1993, 4:92-101.
6. Galloway G.P., Newmeyer J., Knapp T., Stalcup S.A., Smith D. A controlled trial of imipramine for the treatment of methamphetamine dependence. J. Subst. Abuse Treat. 1996, 13:493-497.
7. Gass J.T., Olive M.F. Glutamatergic substrates of drug addiction and alcoholism. Biochem. Pharmacol. 2008, 75:218-265.
8. Grant J.E., Odlaug B.L., Kim S.W. A double-blind, placebo-controlled trial of a glutamate modulating agent, N-acetyl cysteine, in the treatment of trichotillomania. Arch. Gen. Psychiatry 2009, 66(7):756-763.
9. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare Publication (ADM) 76-338 1976, 218-222. National Institute of Mental Health, Rockville.
10. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychiatry 1959, 32:50-55.
11. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
12. Heinzerling K.G., Shoptaw S., Peck J.A., Yang X., Liu J., Roll J., Ling W. Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2006, 85:177-184.
13. Ikemoto S., Glazier B.S., Murphy J.M., McBride W.J. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J. Neurosci. 1997, 17:8580-8587.
14. Jayaram-Lindström N., Hammarberg A., Beck O., Franck J. Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. Am. J. Psychiatry 2008, 165:1442-1448.
15. Kim S.W., Grant J.E., Adson D.E., Shin Y.C. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001, 49:914-921.
16. LaRowe S.D., Mardikian P., Malcolm R., Myrick H., Kalivas P., McFarland K., Saladin M., McRae A., Brady K. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am. J. Addict. 2006, 15:105-110.
17. LaRowe S.D., Myrick H., Hedden S., Mardikian P., Saladin M., McRae A., Brady K., Kalivas P.W., Malcolm R. Is cocaine desire reduced by N-acetylcysteine?. Am. J. Psychiatry 2007, 164:1115-1117.
18. Lee N.K., Rawson R.A. A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev. 2008, 27:309-317.
19. McFarland K., Lapish C.C., Kalivas P.W. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 2003, 23:3531-3537.
20. Meredith C.W., Jaffe C., Ang-Lee K., Saxon A.J. Implications of chronic methamphetamine use: a literature review. Harv. Rev. Psychiatry 2005, 13:141-154.
21. Newton T.F., Roache J.D., De La Garza R.I.I., Fong T., Wallace C.L., Li S.H., Elkashef A., Chiang N., Kahn R. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology 2006, 31:1537-1544.
22. Phillips A.G., LePiane F.G. Reinforcing effects of morphine microinjection onto the ventral tegmental area. Pharmacol. Biochem. Behav. 1980, 12:965-968.
23. Piasecki M.P., Steinagel G.M., Thienhaus O.J., Kohlenberg B.S. An exploratory study: the use of paroxetine for methamphetamine craving. J. Psychoactive Drugs 2002, 34:301-304.
24. Roll J.M., Petry N.M., Stitzer M.L., Brecht M.L., Peirce J.M., McCann M.J., Blaine J., MacDonald M., DiMaria J., Lucero L., Kellogg S. Contingency management for the treatment of methamphetamine use disorders. Am. J. Psychiatry 2006, 163:1993-1999.
25. Rose M.E., Grant J.E. Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Ann. Clin. Psychiatry 2008, 20:145-155.
26. Sheehan D.V. The Anxiety Disease 1983, Scribner's, New York.
27. Shoptaw S., Heinzerling K.G., Rotheram-Fuller E., Steward T., Wang J., Swanson A.N., De La Garza R., Newton T., Ling W. Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2008, 96:222-232.
28. van Wolfswinkel L., van Ree J.M. Effects of morphine and naloxone on thresholds of ventral tegmental electrical self-stimulation. Naunyn. Schmiedebergs. Arch. Pharmacol. 1985, 330:84-92.